Ready reference to common segmental aneusomies by syndromic names, major features and chromosomal locations.
Abnormal gene dosage usually results in recognizable phenotypic abnormalities, especially if it involves a series of contiguous genes. Schmickel (1986) defined contiguous gene syndromes as diseases resulting from loss or gain of a series of adjacent genes. The terms microdeletion and microduplication as well as segmental aneusomy have also been used to describe such losses or gains that may not be readily detectable by Gbanded analysis. The loss (haploinsufficiency) or gain of a series of adjoining genes may result in a direct phenotypic effect and/or cause a genetic regulatory disturbance. Such syndromic gains or losses are often detectable when in situ hybridization of fluorescent labeled DNA probes or array comparative genomic hybridization technique are used (Gersen and Keagle 2005; Stumm et al. 1999; Barch, Knutsen and Spurbeck 1997). Segmental aneusomies generally occur due to homologous pairing between non-allelic low copy repeats (LCR) followed by crossing over. The LCRs, as part of the repetitive DNA sequences range from 1-500 Kb repeats, share >97% base sequence identity and constitute up to five percent of the genomic DNA. They are distributed throughout the genome, but are more concentrated near the centromeres and telomeres. A segment of 300 bp completely identical sequence within the LCRs is adequate for mediating non-allelic homologous or paralogous pairing. This process results in generating both deletion and duplication of a defined segment.